clinical Trials - hiv / aids

Nevada AIDS Research and Education Society offers clinical trials for thetreatment of HIV/AIDS. In addition, we provide clinical trials for problems related to HIV infection and HIV treatment. When available, we offer HIV prevention trials such as potential AIDS vaccines. For more information on each trial, click the underlined, colored title.

After reading the criteria if you are interested in this trial and / or you have additional questions, please call us at (702) 384-9101. Current HIV-related clinical trials include:

HIV Resistance:

This clinical trial is designed to determine the prevalence of antitretroviral drug resistance in treatment naïve HIV-positive patients. Patients must be about to begin their first antiretroviral regimen.

Click Here

Integrase Inhibitor Early Access Protocol:

This clinical trial is designed to provide early access to an integrase inhibitor in combination with optimized background antiretroviral therapy in highly treatment-experienced HIV-1 infected patients with limited to no treatment options.

Click Here

TMC 125 Early Access Program:

This clinical trial is designed to provide early access to TMC 125 in combination with other antiretrovirals in treatment-experienced HIV-1 infected subjects with limited treatment options.

Click Here

HIV-Associated Neuropathy:

This clinical trial is designed to study the use of NGX-4010 for the treatment of painful HIV-associated neuropathy. This treatment is a topical patch embedded with the study medication.

Click Here

Smallpox Vaccine:

This clinical trial is designed to evaluate the safety and immunogenicity of MVA-BN® (IMVAMUNE™) smallpox vaccine in 18-55 year old naïve and previously vaccinated HIV-infected subjects with CD4 counts ≥ 200-500/μl.

Click Here